Risk and Return Analysis of Indian Pharmaceutical Industry – A Study

The risk and returns analysis of the pharmaceutical industry is important in the process of making investment decisions. It allows investors to determine, whether the pharmaceutical stocks are viable in terms of returns when compared to the risks of the stocks, and hence informs investor decision making. The pharmaceutical industry is also viewed as a defensive industry because the demand of medicine is usually relatively stable even in times of economic decline, offering clues on the stability and its capacity to withstand the recession. Additionally, the analysis of the correlation between pharmaceutical stocks and the general market would help investors to have a successful portfolio diversification. By knowing the trend of the pharma stocks against the rest of the sectors, investors will be able to streamline their investments and minimize the risk factor, as a whole. Performance evaluation is another area of application of the risk and return analysis that will be used to ascertain whether the pharmaceutical sector is outperforming or underperforming the entire stock market within a specified timeframe. Lastly, the appraisal of the financial performance of the pharmaceutical industry is insightful information to both policy makers and researchers. It emphasizes the role played by the sector in economic development, job creation, and national building, making it possible to develop evidence-based policies and planning of the healthcare and industrial sectors.
This study examines the risk-return behavior of the pharmaceutical sector in India over a ten-year period from 2015–16 to 2024–25. The pharmaceutical industry plays a critical role in the Indian economy and has gained increased attention from investors, particularly in the post-pandemic period. The primary objective of this research is to analyze the performance and risk characteristics of the sector in relation to the broader market. The study employs both descriptive and analytical research methodologies. Key financial metrics such as the Sharpe Ratio, Beta (β), and correlation coefficient are used to evaluate risk-adjusted returns, systematic risk, and the relationship between the pharmaceutical sector and the market index. Additionally, rolling returns are calculated to assess consistency and variability in sector performance over time. Secondary data has been collected from reliable financial databases and stock market reports for the specified period. The findings of the study provide insights into whether the pharmaceutical sector offers superior risk-adjusted returns and how sensitive it is to overall market movements. The results are expected to assist investors, portfolio managers, and policymakers in making informed decisions regarding investment in the pharmaceutical sector.

Risk, Return and Pharmaceutical Industry

1. William F. Sharpe (1966). Mutual fund performance. Journal of Business, 39(1), 119–138. [Google Scholar] [Crossref]

2. Harry Markowitz (1952). Portfolio selection. Journal of Finance, 7(1), 77–91. [Google Scholar] [Crossref]

3. Eugene F. Fama (1970). Efficient capital markets: A review of theory and empirical work. Journal of Finance, 25(2), 383–417. [Google Scholar] [Crossref]

4. John Lintner (1965). The valuation of risk assets and the selection of risky investments. Review of Economics and Statistics, 47(1), 13–37. [Google Scholar] [Crossref]

5. Michael C. Jensen (1968). The performance of mutual funds in the period 1945–1964. Journal of Finance, 23(2), 389–416. [Google Scholar] [Crossref]

6. Reserve Bank of India (various years). Annual Reports. Mumbai: RBI. [Google Scholar] [Crossref]

7. National Stock Exchange of India (various years). NSE Fact Book. Mumbai: NSE. [Google Scholar] [Crossref]

8. Bombay Stock Exchange (various years). BSE Reports and Publications. Mumbai: BSE. [Google Scholar] [Crossref]

9. SEBI (various years). Handbook of Statistics on Indian Securities Market. Mumbai: SEBI. [Google Scholar] [Crossref]

10. CMIE (various years). Prowess Database. Mumbai: CMIE. [Google Scholar] [Crossref]

11. Damodaran, A. (2012). Investment valuation: Tools and techniques for determining the value of any asset. Wiley Finance. [Google Scholar] [Crossref]

12. Fabozzi, F. J. (2013). Investment management. Pearson Education. [Google Scholar] [Crossref]

13. Hull, J. C. (2018). Risk management and financial institutions. Wiley. [Google Scholar] [Crossref]

14. Bhole, L. M., & Mahakud, J. (2017). Financial institutions and markets: Structure, growth and innovations. McGraw Hill Education. [Google Scholar] [Crossref]

15. Gupta, S., & Jain, P. K. (2020). Risk and return analysis of pharmaceutical sector in India. International Journal of Financial Management, 10(2), 45–60. [Google Scholar] [Crossref]

• Financial Technology (Fintech): Current Research at The Cutting Edge
• Reforming Corporate Governance in Malaysia to Address Fraudulent Financial Reporting Cases
• Stock Market Efficiency and Economic Diversification in Nigeria and South Africa
• Financial Stability and Financial Performance of Small and Medium Tiered Deposit Taking Savings and Credit Cooperatives in Kenya.
• Regulator Sandboxes for DeFi: A Comparative Analysis of Policy Effectiveness in the EU, US, and Asia Pacific